These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10692393)
21. Synergistic effects of inositol 1,3,4,5-tetrakisphosphate on inositol 2,4,5-triphosphate-stimulated Ca2+ release do not involve direct interaction of inositol 1,3,4,5-tetrakisphosphate with inositol triphosphate-binding sites. Loomis-Husselbee JW; Cullen PJ; Dreikausen UE; Irvine RF; Dawson AP Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):811-6. PubMed ID: 8615774 [TBL] [Abstract][Full Text] [Related]
22. Inositol 1,3,4,5-tetrakisphosphate causes release of Ca2+ from permeabilized mouse lymphoma L1210 cells by its conversion into inositol 1,4,5-trisphosphate. Cullen PJ; Irvine RF; Drøbak BK; Dawson AP Biochem J; 1989 May; 259(3):931-3. PubMed ID: 2786415 [TBL] [Abstract][Full Text] [Related]
23. Inositol 1,3,4,5-tetrakisphosphate increases the duration of the inositol 1,4,5-trisphosphate-mediated Ca2+ transient. Joseph SK; Hansen CA; Williamson JR FEBS Lett; 1987 Jul; 219(1):125-9. PubMed ID: 3496245 [TBL] [Abstract][Full Text] [Related]
24. Agonist/inositol trisphosphate-induced release of calcium from murine keratinocytes: a possible link with keratinocyte differentiation. Tang W; Ziboh VA J Invest Dermatol; 1991 Jan; 96(1):134-8. PubMed ID: 1898963 [TBL] [Abstract][Full Text] [Related]
25. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase. Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165 [TBL] [Abstract][Full Text] [Related]
26. Histamine-evoked Ca2+ oscillations in HeLa cells are sensitive to methylxanthines but insensitive to ryanodine. Diarra A; Wang R; Garneau L; Gallo-Payet N; Sauvé R Pflugers Arch; 1994 Jan; 426(1-2):129-38. PubMed ID: 7511800 [TBL] [Abstract][Full Text] [Related]
27. Differential stereoselectivity of D- and L-myo-inositol 1,2,4, 5-tetrakisphosphate binding to the inositol 1,4,5-trisphosphate receptor and 3-kinase. Suh BC; Kim MJ; Choi G; Choi KY; Han JK; Chung SK; Kim KT Neurochem Int; 2000 Jul; 37(1):47-52. PubMed ID: 10781844 [TBL] [Abstract][Full Text] [Related]
28. Calcium release activity and metabolism of inositol 1,4,5-trisphosphate in T cells. Modulation by novel inositol 1,4,5-trisphosphate 5-phosphatase inhibitors. Ward SG; Lampe D; Liu C; Potter BV; Westwick J Eur J Biochem; 1994 Jun; 222(2):515-23. PubMed ID: 8020489 [TBL] [Abstract][Full Text] [Related]
29. Inositol 1,3,4,5-tetrakisphosphate and inositol 1,4,5-trisphosphate act by different mechanisms when controlling Ca2+ in mouse lacrimal acinar cells. Changya L; Gallacher DV; Irvine RF; Petersen OH FEBS Lett; 1989 Jul; 251(1-2):43-8. PubMed ID: 2535675 [TBL] [Abstract][Full Text] [Related]
31. Interactions between inositol tris- and tetrakis-phosphates. Effects on intracellular Ca2+ mobilization in SH-SY5Y cells. Gawler DJ; Potter BV; Gigg R; Nahorski SR Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):163-7. PubMed ID: 1645528 [TBL] [Abstract][Full Text] [Related]
32. Adenophostin A and ribophostin, but not inositol 1,4,5-trisphosphate or manno-adenophostin, activate the Ca2+ release-activated Ca2+ current, I(CRAC), in weak intracellular Ca2+ buffer. Parekh AB; Riley AM; Potter BV Biochem J; 2002 Jan; 361(Pt 1):133-41. PubMed ID: 11742538 [TBL] [Abstract][Full Text] [Related]
33. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase. Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of inositol 1,4,5-trisphosphate metabolism in permeabilised SH-SY5Y human neuroblastoma cells by a phosphorothioate-containing analogue of inositol 1,4,5-trisphosphate. Wojcikiewicz RJ; Cooke AM; Potter BV; Nahorski SR Eur J Biochem; 1990 Sep; 192(2):459-67. PubMed ID: 2209601 [TBL] [Abstract][Full Text] [Related]
35. Inositol trisphosphate analogues induce different oscillatory patterns in Xenopus oocytes. Berridge MJ; Potter BV Cell Regul; 1990 Aug; 1(9):675-81. PubMed ID: 1706629 [TBL] [Abstract][Full Text] [Related]
38. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor. Safrany ST; Sawyer DA; Nahorski SR; Potter BV Chirality; 1992; 4(7):415-22. PubMed ID: 1334423 [TBL] [Abstract][Full Text] [Related]
39. Regulation of histamine- and UTP-induced increases in Ins(1,4,5)P3, Ins (1,3,4,5)P4 and Ca2+ by cyclic AMP in DDT1 MF-2 cells. Sipma H; Duin M; Hoiting B; den Hertog A; Nelemans A Br J Pharmacol; 1995 Jan; 114(2):383-90. PubMed ID: 7881738 [TBL] [Abstract][Full Text] [Related]
40. Ins(1,4,5)P3 metabolism and the family of IP3-3Kinases. Pattni K; Banting G Cell Signal; 2004 Jun; 16(6):643-54. PubMed ID: 15093605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]